MOTS Stock Overview
Operates as a medical technology company in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
My Notes
Capture your thoughts, links and company narrative
Motus GI Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0001 |
| 52 Week High | US$1.70 |
| 52 Week Low | US$0.000001 |
| Beta | 1.63 |
| 1 Month Change | 9,900.00% |
| 3 Month Change | -99.79% |
| 1 Year Change | -99.99% |
| 3 Year Change | -100.00% |
| 5 Year Change | -100.00% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Motus GI regains compliance with minimum bid price requirement
Aug 11Motus GI Holdings announces 1-for-20 reverse stock split to satisfy Nasdaq's minimum bid requirement
Jul 25Motus GI starts enrollment in Pure-Vu System EU study
Jun 16Motus GI shares rocket 55% on FDA 510(k) clearance of Pure-Vu System
Apr 30Here's Why Motus GI Holdings (NASDAQ:MOTS) Can Manage Its Debt Despite Losing Money
Mar 02
Shareholder Returns
| MOTS | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -50.0% | -1.5% | -2.4% |
| 1Y | -100.0% | 10.0% | 23.4% |
Return vs Industry: MOTS underperformed the US Medical Equipment industry which returned 10.1% over the past year.
Return vs Market: MOTS underperformed the US Market which returned 23.3% over the past year.
Price Volatility
| MOTS volatility | |
|---|---|
| MOTS Average Weekly Movement | 17,212.6% |
| Medical Equipment Industry Average Movement | 7.6% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: MOTS's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: MOTS's weekly volatility has increased from 7858% to 17213% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 15 | n/a | www.motusgi.com |
Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016.
Motus GI Holdings, Inc. Fundamentals Summary
| MOTS fundamental statistics | |
|---|---|
| Market cap | US$719.00 |
| Earnings (TTM) | -US$16.10m |
| Revenue (TTM) | US$327.00k |
0.0x
P/S Ratio0.0x
P/E RatioIs MOTS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MOTS income statement (TTM) | |
|---|---|
| Revenue | US$327.00k |
| Cost of Revenue | US$407.00k |
| Gross Profit | -US$80.00k |
| Other Expenses | US$16.02m |
| Earnings | -US$16.10m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.24 |
| Gross Margin | -24.46% |
| Net Profit Margin | -4,924.16% |
| Debt/Equity Ratio | 75.0% |
How did MOTS perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 06:43 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/03/31 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Motus GI Holdings, Inc. is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Benjamin Haynor | Alliance Global Partners |
| Kyle Bauser | Colliers Securities |
| Yi Chen | H.C. Wainwright & Co. |